Skip to main content
Theodosia Kalfa, MD, Pediatric Hematology & Oncology, Cincinnati, OH

TheodosiaAKalfaMD

Pediatric Hematology & Oncology Cincinnati, OH

Pediatric Anemia and Red Blood Cell Hematology

Professor of Pediatrics

Dr. Kalfa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kalfa's full profile

Already have an account?

Summary

  • Dr. Theodosia Kalfa is a pediatric hematologist/oncologist in Cincinnati, OH. She received her medical degree from Aristotle University of Thessaloniki School of Medicine and has been in practice 27 years. She also speaks multiple languages, including Greek. She is experienced in thalassemias, bone marrow failure syndromes, hemolytic anemia, pediatric hematology and oncology, and sickle cell disease. She has more than 80 publications and over 500 citings.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Pediatric Hematology/Oncology, 2000 - 2003
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Pediatrics, 1996 - 1999
  • Aristotle University of Thessaloniki School of Medicine
    Aristotle University of Thessaloniki School of MedicineClass of 1990

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2021 - 2025
  • KY State Medical License
    KY State Medical License 2021 - 2025
  • OH State Medical License
    OH State Medical License 2003 - 2024
  • NC State Medical License
    NC State Medical License 1996 - 2009
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • niche  
    Kalfa, Blood

Abstracts/Posters

  • Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)
    Theodosia A. Kalfa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • VPS4A mutations Cause a Syndrome with Dyserythropoiesis, Hemolytic Anemia, and Neurodevelopmental Delay
    Theodosia A. Kalfa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Laboratory and Translational Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Evaluation of Phenotype-Genotype Correlation in Two Common PIEZO1 Mutations p.R2456H and p.L2495_E2495dup 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • FORMA Therapeutics Announces Clinical Data for Sickle Cell Disease Candidate FT-4202, Demonstrating Multi-Modal Activity of PKR Activation Increases Oxygen Affinity and Decreases Sickle Hemoglobin Polymerization, at 61st Annual ASH Meeting
    FORMA Therapeutics Announces Clinical Data for Sickle Cell Disease Candidate FT-4202, Demonstrating Multi-Modal Activity of PKR Activation Increases Oxygen Affinity and Decreases Sickle Hemoglobin Polymerization, at 61st Annual ASH MeetingDecember 9th, 2019

Grant Support

  • The Role of Erythroblastic Islands in Anemia of InflammationNIH-NHLBI2020–2024
  • Rho GTPases in Terminal Erythroid MaturationNIH-NHLBI2012–2016
  • RAC1 And RAC2 Guanosine Triphosphatases In Erythroid Function And DifferentiationNational Heart, Lung, And Blood Institute2010–2012
  • RAC1 And RAC2 Guanosine Triphosphatases In Erythroid Function And DifferentiationNational Heart, Lung, And Blood Institute2008–2009

Professional Memberships

Other Languages

  • Greek